期刊文献+

重组人蛋白C在HEK293细胞中的表达与鉴定 被引量:1

Expression of Recombinant Human Protein C in HEK293 Cells and Identification of Expressed Product
在线阅读 下载PDF
导出
摘要 目的获得转染人蛋白CcDNA的工程细胞株,实现重组蛋白C的表达。方法将构建好的重组表达载体pIRES-hPC用脂质体介导的方法转染HEK293细胞,经G418加压筛选、细胞有限稀释法等获得克隆细胞株,收集无血清培养上清,浓缩后进行鉴定。结果经G418筛选得到了21株克隆化细胞,SDS-PAGE和Westernblot鉴定表明,表达产物含有人蛋白C,且具有抗凝活性。结论在哺乳动物细胞中已成功表达重组人蛋白C,为进一步深入研究及产业化奠定了基础。 Objective To obtain a recombinant cell strain transfected with human protein C cDNA and e xpress the protein. Methods Transfect HEK293 cells with a constructed recombinant expression vector pIRES-h PC in the mediation of liposome.Select positive transfectants by G418 pressure s creening and clone the single cell colony by limiting dilution.Culture the clone d cells in a serum-free medium for 3 days,collect the culture supernatant and c oncentrate with 70% PEG8000.Identify the expressed product by SDS-PAGE and West ern blot. Results A total of 21 cloned cell strains were obtained by G418 pressure screening.S DS- PAGE and Western blot proved that the human protein C with anticoagulation activ ity was expressed. Conclusion Recombinant human protein C was successfully expressed in mammal animal cells.It laid a foundation of further study and industrialization of human protein C.
出处 《中国生物制品学杂志》 CAS CSCD 2005年第4期294-296,共3页 Chinese Journal of Biologicals
基金 军事医学科学院创新基金资助项目(020901)
关键词 重组人蛋白C HEIQ93细胞中 表达 鉴定 抗凝活性 Human protein C HEK293 cells Expression
  • 相关文献

参考文献8

  • 1Vukovich T, Auberger K, Weil J, et al. Replacement therapy for a homozygous protein C deficiency with activated protein C. Am J Hematol,1993,44: 218-225.
  • 2Garber K. Protein C may be sepsis solution. Nature Biotech, 2000,18:917-923.
  • 3贾莉玮,吕茂民,沈永才,赵保全,张亚东,章金刚.人蛋白CcDNA基因的克隆及序列分析[J].生物技术通报,2003,19(4):26-28. 被引量:3
  • 4吕茂民,贾莉玮,王建国,杨姝,熊景峰,章金刚.G418抗性HEK293细胞的培育[J].中国实验动物学报,2003,11(1):5-6. 被引量:6
  • 5Foster DC,Rudinski MS, Schach BG, et al. Propeptide of human protein C is necessary for γ-carboxylation. Biochemistry, 1987,26: 7003-7014.
  • 6Foster DC,Sprecher CA, Holly RD,et al. Endoproteolytic processing of the dibasic cleavage site in the human protein C precursor in transfected mammalian cells: effects of sequence alterations on efficiency of cleavage. Biochemistry, 1990,29:347-356.
  • 7Foster DC, Holly RD, Sprecher CA, et al. Endoproteolytic processing of the human protein C precursor by the yeast Kex2 endopeptidase coexpressed in the mammalian cells. Biochemistry, 1991,30:367-378.
  • 8贾莉玮,吕茂民,徐斯日古愣,沈永才,赵保全,章金刚.人蛋白C cDNA突变体的设计、克隆与序列分析[J].中国生物制品学杂志,2003,16(5):257-260. 被引量:2

二级参考文献14

  • 1Estnon C. Crit Care Med,2000, 28(9 Suppl. ).S44.
  • 2Vukovich T, Auberger K, Weil J,et al. Am J Hematol,1993, 44:218.
  • 3Garber K. Nature Biotech,2000, 18:917.
  • 4Bernard GR, Vincent JL, Laterre PF, et al. N Engl J Med,2001, 344:699.
  • 5Bernard GR, Hartman DL, Helterbrand JD, et al. Abstr Crit Care Med, 1998, 27 :S4.
  • 6Ebina Y,Ellis L, Jamagin K,et al.The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signaling. Cell,1985,40: 747-758.
  • 7Esmon C. The prptein C pathways. Crit Care Med, 2000,28(9):44-48.
  • 8Vukovich T, Auberger K, Weil J, et al. Successful treatment of deep vein thrombosis in a homozygous protein C deficiency with activated protein C. Am J Hematol, 1993,44:218-219.
  • 9Gather K. Protein C may be sepsis sulution. Nature Biotech, 2000, 18:917-918.
  • 10Annane D. Sebille. V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to certicotropln. JAMA 2000,283:1038-1045.

共引文献7

同被引文献67

  • 1吕茂民,王娜,王栋,于群,章金刚.凝血因子Ⅶ基因表达载体的构建及其在BHK细胞中的表达[J].中国生物工程杂志,2005,25(1):44-47. 被引量:6
  • 2吕茂民,周华蕾,姚站馨,章金刚.人凝血因子ⅦcDNA基因的克隆与鉴定[J].生物技术通报,2007,23(4):132-134. 被引量:1
  • 3Kheirabadi BS, Acheson EM, Deguzman R, et al. The potential utility of fibrin sealant dressing in repair of vascular injury in swine. Trauma, 2007, 62(1): 94-103.
  • 4Schenk WG III, Burks SG, Gagne P J, et al. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg, 2003, 237(6): 871-876.
  • 5Kubota M, Okuyama N, Hirayama Y. A new method to close an intestinal wall defect using fibrin glue and polyglycolic acid felt sealant. Peditr Surg, 2007, 42(7): 1225-1230.
  • 6De Cristofaro R, Akhavan S, Altomare C, et al. A natural prothrombin mutant reveals an unexpected influence of A-chain structure on the activity of human ct-thrombin. J Biol Chem, 2004, 279(13): 13035-13043.
  • 7Bishop PD, Lewis KB, Schultz J, et al. Comparison of recombinant human thrombin and plasma-derived human alpha-thrombin. Semin Thromb Hemost, 2006, 32(S1): 86 -97.
  • 8Chapman WC, Singla N, Genyk Y, et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. Am Coll Surg, 2007, 205(2): 256 -265.
  • 9Anderson CD, Bowman LJ, Chapman WC. Topical use of recombinant human thrombin for operative hemostasis. Expert Opin Biol Ther, 2009, 9(1): 133-137.
  • 10Broze GJ Jr, Majerus PW. Purification and properties of human coagulation factor VII. J Biol Chem, 1980, 255(4):1242-1247.

引证文献1

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部